• Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy

Browse Tag

Leukemia

FDA Logo
June 2, 2013
News Center/Pharmaceutical News

FDA approves Gleevec for children with acute lymphoblastic leukemia

[column]The U.S. Food and Drug Administration has approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). ALL is the most common type of pediatric cancer, affecting approximately 2,900 children annually,

More
FDA Logo
News Center/Pharmaceutical News

FDA approves Gleevec for children with acute lymphoblastic leukemia

June 2, 2013

[column]The U.S. Food and Drug Administration has approved a new use of Gleevec (imatinib) to treat children newly diagnosed with

More
  • How To Overcome Common Breastfeeding Challenges
  • Can You Sue Your Doctor for Blindness Caused by Elmiron?
  • Experts advise European SME packaging firms to expand or seek acquisition prior to Pharmapack Europe
  • FIP advances sustainable health systems by providing new guidance for self-managing reflux symptoms
  • APAC overview: trends, challenges, and possibilities for growth in the MarTech sector

© 2010-2022 PharmaMirror.com - All Rights Reserved.

  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
  • Home
  • Articles
  • Global News
  • Interest
  • Health Tips
  • Write for Us
    • Contact Us
      • About
      • Privacy Policy
Go toTop